Document is current

Any future updates will be listed below

264 Allogeneic natural killer cells engineered to express HER2-directed CAR, interleukin-15 and TGFß dominant negative receptor effectively control HER2+ tumors

Crossref DOI link: https://doi.org/10.1136/jitc-2022-SITC2022.0264

Published Online: 2022-11-07

Published Print: 2022-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark